|
|
|
市場調査レポート
世界のカテーテル市場
The Global Catheters Market
| 発行 |
BCC Research |
| 出版日 |
2009年08月 |
商品コード |
97786 |
| ページ情報 |
英文 165 pages |
| 価格 |
|
|
Abstract
REPORT HIGHLIGHTS
- The global catheter market amounted to $14.5 billion in 2008, and was
projected to increase to nearly $18 billion in 2009. It is expected to reach
$32.1 billion in 2014, for a 5-year compound annual growth rate (CAGR) of
12.3%.
- The market' s cardiovascular segment is the largest with sales of $6
billion in 2008. That is projected to increase to $7.1 billion in 2009, and to
rise at a CAGR of 10.2% to $11.6 billion in 2014.
- The second-largest segment is urology, with revenue of $4.4 billion in
2008, which is expected to reach nearly $6 billion in 2009, and increase to
$13.2 billion in 2014, for the highest CAGR among all segments at 17.1%.
INTRODUCTION
STUDY GOALS AND OBJECTIVES
BCC Research' s goal in conducting this study was to determine the present
status of the worldwide catheter market and to evaluate its potential over the
5-year period from 2009 to 2014. An assessment of the worldwide catheter
market was performed while considering all of its important segments, such as
cardiovascular, urological, neurovascular, intravenous, and specialty
catheters.
REASONS FOR DOING THE STUDY
Catheterization procedures have steadily increased as interventional and
less-invasive procedures have become more popular. Catheters are vital to the
completion of many procedures, and some procedures or interventions,
particularly in cardiovascular surgery and neurosurgery, could not be done
without the use of catheters. In conducting this study, BCC was interested in
determining the areas of catheter applications poised for growth and the
reasons for their growth. New products and their future impact on the market
were also assessed.
SCOPE OF REPORT
BCC studied the current catheter market, anticipated market trends, and then
projected total and sectional market revenues through 2014. The report
includes technological descriptions, issues, applications, market factors, and
market metrics.
The scope of this study encompasses the five major application segments of the
catheter market. BCC Research analyzes each type of catheter segment,
determines its current market status, examines its impact on future markets,
and presents growth forecasts over the next 5 years. Catheter material
analysis, regulatory issues, and the latest technological trends are also
covered. Other influential factors such as patents and company profiles are
discussed.
METHODOLOGY
Both primary and secondary research methodologies were used in this study.
BCC Research presents an analysis of each segment of the catheters industry
depending on its application, using a base year of 2008. Estimated values used
are based on manufacturers' net revenues.
INTENDED AUDIENCE
This study will be of interest to catheter and device manufacturers, catheter
material manufacturers, and venture capitalists and financial institutions
involved in the healthcare industry.
INFORMATION SOURCES
Major sources of primary research information include information from
industry personnel. Secondary research sources include industry association
and company press releases, company Web sites, financial and trade
information, and government sources.
Table of Contents
Chapter- 1: INTRODUCTION -- Complimentary 3
- STUDY GOALS AND OBJECTIVES 1
- REASONS FOR DOING THE STUDY 1
- SCOPE OF REPORT 1
- METHODOLOGY 1
- INTENDED AUDIENCE 2
- INFORMATION SOURCES 2
- ANALYST CREDENTIALS 2
- RELATED REPORTS 2
- BCC ONLINE SERVICES 2
- DISCLAIMER 3
Chapter-2: SUMMARY 3
- SUMMARY 4
- SUMMARY TABLE GLOBAL CATHETER MARKET, THROUGH 2014 ($ MILLIONS) 5
- SUMMARY FIGURE GLOBAL CATHETER MARKET, 2008 AND 2014 (%) 6
Chapter-3: OVERVIEW OF GLOBAL CATHETER INDUSTRY 19
- ORIGINS 7
- CATHETER CONSTRUCTION 8
- CATHETER APPLICATIONS 8
- TYPES OF CATHETERS 9
- CARDIOVASCULAR CATHETERS 9
- Diagnostic Procedures and Cardiac Catheterization 10
- TABLE 1 INDICATIONS FOR CARDIAC CATHETERIZATION 10
- TABLE 1 (CONTINUED) 11
- TABLE 2 TYPES OF CARDIAC CATHETERS 11
- Angiography Catheters 11
- Electrophysiology (EP) Catheters 12
- Percutaneous Coronary Intervention (PCI) Catheters 13
- TABLE 3 PTCA PROCEDURES 13
- Rapid Exchange PTCA Balloon Catheters 14
- Over - the-Wire PTCA Catheters 14
- Guiding Catheter 14
- UROLOGICAL CATHETERS 15
- Types of Urinary Catheterizations 16
- Intermittent Catheterization 16
- Indwelling Catheterization 16
- Suprapubic Catheterization 17
- Male External Condom Catheters 18
- NEUROVASCULAR CATHETERS 18
- INTRAVENOUS (IV) CATHETERS 19
- Single-Lumen Catheters 19
- Multi-Lumen Catheter 20
- Specialty IV Catheters 20
- Peripheral Vein Catheter 20
- Central Venous Catheter 20
- Peripherally Inserted Central Catheters (PICCs) 21
- TABLE 4 COMPLICATIONS DUE TO IV CATHETERS 22
- SPECIALTY CATHETERS 22
- Thermodilution Catheters 22
- Suction Catheters 23
- Oximetry Catheters 23
- END-USER PREFERENCES 24
- SIZE OF CATHETER 24
- MATERIAL USED 24
- COATING 25
- DURATION OF CATHETER IN THE BODY 25
- INFECTION 25
- COST 25
Chapter-4: CATHETERS AND WORLD DEMOGRAPHICS 4
- TABLE 5 U.S. RATES OF CARDIOVASCULAR PROCEDURES, 2004 AND 2006*
(THOUSANDS) 26
- WORLDWIDE PROCEDURES 27
- TABLE 6 SELECTED WORLDWIDE CORONARY PROCEDURES, 2008 (PER 100,000
POPULATION) 27
- WORLDWIDE ECONOMIC DEMOGRAPHICS 28
- TABLE 7 HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP BY COUNTRY, 1980 -
2005 (%) 28
- TABLE 7 (CONTINUED) 29
- WORLDWIDE POPULATION GROWTH 29
Chapter-5: CATHETER MATERIALS 7
- KEY CHARACTERISTICS OF CATHETER MATERIALS 30
- TABLE 8 CHARACTERISTICS OF CATHETER MATERIALS 30
- SURFACE CHARACTERISTICS 31
- RADIOPACITY 31
- COMPONENT MATERIALS 31
- LATEX 32
- SILICONE 32
- TEFLON (FLUOROPOLYMER) 33
- POLYURETHANE 33
- POLYVINYL CHLORIDE (PVC) 33
- POLYETHYLENE 33
- CATHETER COATINGS 34
- SILICONE ELASTOMER 34
- HYDROPHILIC COATING 34
- ANTIMICROBIAL COATING 35
- Silver Coating 35
- ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS 35
- TABLE 9 ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS 36
Chapter-6: ANALYSIS OF THE GLOBAL CATHETER MARKET 26
- FACTORS INFLUENCING MARKET GROWTH 37
- FIGURE 1 FACTORS INFLUENCING THE MEDICAL DEVICE MARKET 38
- DEMOGRAPHICS 38
- SURGICAL AND MEDICAL TRENDS 38
- Catheter Reuse 39
- REIMBURSEMENT 39
- EMERGING TECHNOLOGY 39
- PRODUCT DISTRIBUTION 40
- PURCHASING TRENDS 40
- TREATMENT COSTS 40
- LEADING MANUFACTURERS 41
- TABLE 10 REVENUES OF KEY CATHETER MANUFACTURERS, 2007 AND 2008 ($
MILLIONS) 41
- KEY MARKET DRIVERS 41
- INCREASE IN PROCEDURES HAS LED TO INCREASED DEMAND FOR CATHETERS 42
- INCREASED DEMAND FOR DISPOSABLE CATHETERS DUE TO RISK OF INFECTION AND
AIDS 42
- NEW TECHNOLOGIES IN CATHETERS HAVE INCREASED CATHETER USE 42
- INCREASE IN MINIMALLY INVASIVE PROCEDURES REQUIRING CATHETERS HAS
INCREASED SALES 42
- ADVANCES IN IMAGING TECHNOLOGY HAS LED TO NEW APPLICATIONS REQUIRING THE
USE OF CATHETERS 43
- KEY MARKET RESTRAINTS 43
- PRICE EROSIONS DUE TO FIERCE COMPETITION ARE SHRINKING REVENUES 43
- LONG FDA APPROVAL TIMES ARE RESULTING IN DELAYED LAUNCHES OF NEW PRODUCTS
43
- REIMBURSEMENT ISSUES HAVE AFFECTED THE USE OF TECHNOLOGICALLY ADVANCED
CATHETERS 44
- EXPERIENCED PHYSICIANS OFTEN ARE RELUCTANT TO ACCEPT NEW DEVICE
TECHNOLOGIES 44
- GLOBAL CATHETER REVENUE ANALYSIS 44
- TABLE 11 PROJECTED GLOBAL CATHETER MARKET BY SEGMENT, THROUGH 2014 ($
MILLIONS 45
- FIGURE 2 PROJECTED GLOBAL CATHETER MARKET, 2009 ($ MILLIONS) 45
- FIGURE 2 (CONTINUED) 46
- TABLE 12 PROJECTED GLOBAL CATHETER MARKET SHARES BY SEGMENT, 2008 AND 2014
(%) 47
- FIGURE 3 GLOBAL CATHETER MARKET SHARES BY SEGMENT, 2009 AND 2014 (%) 48
- MARKET SHARE FORECAST 49
- CONSEQUENCES OF THE 2008 ECONOMIC SLOWDOWN 49
- REVENUES, SHARES, AND PROJECTIONS BY REGION 50
- TABLE 13 PROJECTED GLOBAL CATHETER MARKET BY REGION, THROUGH 2014 ($
MILLIONS) 50
- TABLE 14 PROJECTED GLOBAL CATHETER MARKET SHARES BY REGION, 2008 AND 2014
(%) 51
- U.S. Catheter Market 51
- European Catheter Market 52
- Rest of the World Catheter Market 53
- REPROCESSED CATHETERS 54
- COMPETITIVE STRUCTURE 55
- TYPES OF COMPETITION 56
- TIERS OF COMPETITION 56
- MERGERS AND ACQUISITIONS 56
- TABLE 15 SELECTED KEY MERGERS AND ACQUISITIONS WITHIN THE CATHETER MARKET,
2008-2009 ($) 57
- END-USER GROUPS 57
- DISTRIBUTION STRUCTURE 58
- PURCHASE STRUCTURE 59
- COMPETITIVE FACTORS 59
- Regulatory Environment 59
- Pricing 59
- Catheter Properties 60
- Branding 60
- ANALYSIS OF THE GLOBAL CATHETER MARKET BASED ON STRENGTHS, OPPORTUNITIES,
WEAKNESSES, AND THREATS 60
- STRENGTHS 60
- OPPORTUNITIES 61
- WEAKNESSES 61
- THREATS 62
Chapter-7: CARDIOVASCULAR CATHETERS 11
- KEY MARKET CHALLENGES 63
- CONTROVERSY REGARDING THE USE OF DRUG-ELUTING STENTS AFFECTS CATHETER USE
63
- PHARMACOLOGICAL APPROACHES ARE THREATENING CATHETER DEMAND 64
- LACK OF CLINICAL DATA IS HINDERING ACCEPTANCE OF NEWER CATHETERS BY
PHYSICIANS 64
- KEY MARKET DRIVERS 64
- INCREASES IN THE INCIDENCE OF CARDIOVASCULAR DISEASES IS DRIVING THE
NUMBER OF PROCEDURES 64
- POPULARITY OF ANGIOPLASTY AND STENTS OVER BYPASS SURGERY IS LEADING TO AN
INCREASE IN THE USE OF CARDIAC CATHETERS 65
- ANGIOGRAPHY IS DRIVING THE INCREASE IN THE NUMBER OF DIAGNOSTIC PROCEDURES
65
- INTERVENTIONAL CARDIAC PROCEDURES ARE MORE EFFECTIVE THAN
PHARMACEUTICAL-BASED THERAPIES 66
- KEY MARKET RESTRAINTS 66
- CONSTANT PRICE EROSION IS LEADING TO DECREASED REVENUES 66
- DECREASE IN RESTENOSIS IS AFFECTING THE NUMBER OF STENT PROCEDURES
PERFORMED 66
- CATHETER USAGE IS RESTRAINED DUE TO LOW REIMBURSEMENT RATES 67
- CARDIOVASCULAR CATHETER MARKET ANALYSIS 67
- TABLE 16 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE, THROUGH
2014 ($ MILLIONS) 67
- FIGURE 4 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE, 2014 ($
BILLIONS) 68
- ANGIOGRAPHY 69
- ELECTROPHYSIOLOGY/MAPPING CATHETERS 69
- BALLOON CATHETERS 69
- GUIDING CATHETERS 70
- INTRAVASCULAR ULTRASOUND CATHETERS 70
- TABLE 17 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE OF
PROCEDURE, 2009 AND 2014 (%) 70
- FIGURE 5 GLOBAL CARDIOVASCULAR CATHETER SHARES BY REGION, 2009 AND 2014
(%) 71
- MARKET SHARES BY COMPANY 72
- TABLE 18 GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY COMPANY, 2008 (%)
72
- FIGURE 6 GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY COMPANY, 2008 (%)
72
- CARDIOVASCULAR CATHETER PRODUCTS BY COMPANY 73
- COMPETITIVE STRUCTURE 73
Chapter-8: UROLOGY CATHETER MARKET 8
- KEY MARKET CHALLENGES 74
- USE OF LONG-TERM CATHETERS IS THREATENING THE GROWTH OF DISPOSABLE
CATHETERS 74
- USE OF CATHETERS HAS DECLINED DUE TO AN INCREASE IN THE NUMBER OF URINARY
TRACT INFECTIONS (UTI) 74
- SOME PHYSICIANS ARE NOT READY TO ACCEPT NEW PRODUCTS DUE TO A LACK OF
CLINICAL DATA 75
- KEY MARKET DRIVERS 75
- INCREASE IN UROLOGY PROCEDURES IS LEADING TO INCREASED CATHETER USE 75
- CATHETERS WITH ANTIMICROBIAL COATINGS ARE INCREASING CONFIDENCE IN THE USE
OF CATHETERS 75
- SOME PRODUCTS CAN BE USED BY PATIENTS THEMSELVES, INCREASING PATIENT
ADOPTION 76
- KEY MARKET RESTRAINTS 76
- LENGTHY FDA APPROVAL TIMES HAVE LED TO DELAYS IN THE LAUNCH OF EFFECTIVE
ANTIMICROBIAL CATHETERS 76
- OCCURRENCES OF UTI IS DISCOURAGING CATHETER USAGE 76
- UROLOGY CATHETER MARKET ANALYSIS 76
- TABLE 19 PROJECTED GLOBAL UROLOGY CATHETER MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 77
- FIGURE 7 PROJECTED GLOBAL UROLOGY CATHETER MARKET BY TYPE, 2008-2014 ($
MILLIONS) 78
- MARKET SHARES AND PROJECTIONS BY TYPE OF CATHETER 78
- TABLE 20 PROJECTED GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE, 2008 AND
2014 (%) 79
- FIGURE 8 PROJECTED GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE, 2014 (%)
79
- Intermittent Catheters 79
- Foley Catheters 80
- Other Catheters 80
- MARKET SHARES BY COMPANY 80
- TABLE 21 GLOBAL UROLOGY CATHETER MARKET SHARES BY COMPANY, 2008 (%) 81
- UROLOGY CATHETER PRODUCTS BY COMPANY 81
- COMPETITIVE STRUCTURE 81
Chapter-9: NEUROVASCULAR CATHETER MARKET 5
- KEY MARKET CHALLENGES 82
- COST OF SPECIALIZED MICROCATHETERS AFFECTS THEIR ADOPTION 82
- KEY MARKET DRIVERS 82
- ADVANCES IN IMAGING TECHNOLOGIES ARE CREATING NEW AREAS OF DIAGNOSIS AND
TREATMENT 82
- STENTING AND ANEURYSM TREATMENTS ARE INCREASING CATHETER USE 82
- NEW CATHETER TECHNOLOGIES ARE IMPROVING PROCEDURES AND INCREASING DEMAND 83
- MARKET POTENTIAL EXISTS IN UNMET TREATMENT OPTIONS 83
- KEY MARKET RESTRAINTS 83
- INCREASED AVAILABILITY OF PHARMACOLOGICAL TREATMENT OPTIONS IS INHIBITING
NEUROCATHETER USE 83
- SHORTAGE OF PROFESSIONALS QUALIFIED TO PERFORM INVASIVE NEUROLOGICAL
PROCEDURES IS INFLUENCING NEUROCATHETER SALES 84
- MANY PATIENTS DIE BEFORE RECEIVING TREATMENT 84
- NEUROVASCULAR CATHETER MARKET ANALYSIS 84
- TABLE 22 PROJECTED GLOBAL NEUROVASCULAR CATHETER MARKET, THROUGH 2014 ($
MILLIONS) 85
- MARKET SHARES BY COMPANY 85
- TABLE 23 GLOBAL NEUROVASCULAR CATHETER MARKET SHARES BY COMPANY, 2008 (%)
86
- NEUROVASCULAR PRODUCTS, BY COMPANY 86
- COMPETITIVE STRUCTURE 86
Chapter-10: INTRAVENOUS CATHETER MARKET 6
- KEY MARKET CHALLENGES 87
- LACK OF CLINICAL DATA CHALLENGES ADOPTION OF NEW IV CATHETERS 87
- MANUFACTURERS FACE PRICE EROSION AND FIERCE COMPETITION 87
- KEY MARKET DRIVERS 88
- STRICT CATHETER REPLACEMENT RULES ARE INCREASING SALES 88
- IV CATHETERS WITH ANTIMICROBIAL COATINGS IMPROVE THEIR MARKETABILITY 88
- INCREASED APPLICATIONS AND INTRODUCTION OF NEW TECHNOLOGY BOOSTS IV
CATHETER SALES 88
- KEY MARKET RESTRAINTS 89
- CONSTANT PRICE EROSION IS LEADING REVENUE LOSSES 89
- REIMBURSEMENT ISSUES REDUCE THE USE OF HIGH-END IV CATHETERS 89
- INTRAVENOUS CATHETER MARKET ANALYSIS 89
- TABLE 24 PROJECTED GLOBAL IV CATHETER MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 89
- FIGURE 9 PROJECTED GLOBAL IV CATHETER MARKET, 2008-2014 ($ MILLIONS) 90
- MARKET SHARES AND PROJECTIONS BY CATHETER TYPE 90
- TABLE 25 PROJECTED GLOBAL INTRAVENOUS CATHETER SHARES BY TYPE, 2008 AND
2014 (%) 91
- MARKET SHARES BY COMPANY 91
- TABLE 26 GLOBAL INTRAVENOUS CATHETER MARKET SHARES BY COMPANY, 2008 (%) 92
- IV CATHETER PRODUCTS BY COMPANY 92
- COMPETITIVE STRUCTURE 92
Chapter-11: SPECIALTY CATHETERS 5
- KEY MARKET CHALLENGES 93
- LACK OF CLINICAL DATA TO SUPPORT EFFICACY 93
- KEY MARKET DRIVERS 93
- DEMAND FOR ENHANCED MONITORING DEVICES IS LEADING TO MORE SALES 93
- THE EFFECTIVENESS OF SPECIALTY CATHETERS IS FUELING INTEREST BY MEDICAL
STAFF AND PROMOTING THEIR USE 93
- KEY MARKET RESTRAINTS 94
- HIGH PRICE OF CATHETERS INHIBITS SALES 94
- LIMITED INTERNATIONAL EXPANSION DUE TO THE HIGHER COST OF SPECIALTY
CATHETERS 94
- SPECIALTY CATHETER MARKET ANALYSIS 94
- TABLE 27 PROJECTED GLOBAL SPECIALTY CATHETER MARKET BY TYPE, THROUGH 2014
($ MILLIONS) 94
- FIGURE 10 PROJECTED GLOBAL SPECIALTY CATHETER MARKET BY TYPE, 2008-2014 ($
MILLIONS) 95
- MARKET SHARES AND PROJECTIONS BY CATHETER TYPE 95
- TABLE 28 PROJECTED GLOBAL SPECIALTY CATHETER MARKET SHARES BY TYPE, 2008
AND 2014 (%) 96
- MARKET SHARES BY COMPANY 96
- TABLE 29 SPECIALTY CATHETER MARKET SHARES BY COMPANY, 2008 (%) 97
- SPECIALTY PRODUCTS BY COMPANY 97
- COMPETITIVE STRUCTURE 97
Chapter-12: GOVERNMENT REGULATIONS AND ISSUES 18
- CATHETER MARKET REGULATIONS 98
- CLASS I MEDICAL DEVICES 98
- CLASS II 98
- CLASS III 98
- TABLE 30 CATHETER TYPES AND CLASS 99
- TABLE 30 (CONTINUED) 100
- TABLE 30 (CONTINUED) 101
- FDA APPROVAL PROCESS 101
- PREMARKET NOTIFICATION 510(K) 102
- PREMARKET APPROVAL (PMA) 103
- INVESTIGATIONAL DEVICE EXEMPTION (IDE) 104
- ESTABLISHMENT REGISTRATION FORM 105
- MEDICAL DEVICE LISTING 105
- QUALITY SYSTEM (QS) REGULATION 106
- LABELING 107
- MEDICAL DEVICE REPORTING 107
- EUROPEAN HEALTHCARE STANDARDS 107
- REGULATORY DIRECTIVES 108
- The Active Implantable Medical Device Directive (AIMD) [90/385/EEC] 108
- The Medical Device Directive (MDD) [93/42/EEC] 108
- The In Vitro Medical Devices Directive (IVD) [98/79/EC] 108
- JAPANESE STANDARDS 109
- CHINESE STANDARDS 109
- INTERNATIONAL ORGANIZATION FOR STANDARDS (ISO) 110
- TABLE 31 CATHETER ISO NUMBERS 110
- DIFFERENCES IN EUROPEAN AND U.S. REGULATIONS 110
- RECENT FDA 510(K) APPROVALS, EUROPEAN UNION CE APPROVALS, JAPANESE
APPROVALS. 111
- TABLE 32 SELECTED U.S. FDA 510(K) APPROVALS, CE MARK APPROVAL, AND
JAPANESE APPROVAL OF CATHETERS, 2007 - 2009 111
- TABLE 32 (CONTINUED) 112
- TABLE 32 (CONTINUED) 113
- FDA RECALLS 113
- MISLABELING 113
- NONSTERILE CONDITIONS 114
- MANUFACTURING DEFECTS/MALFUNCTIONS 114
- TABLE 33 U.S. CATHETER RECALLS IN 2008, 2009 114
- TABLE 33 (CONTINUED) 115
Chapter-13: PATENT ANALYSIS 11
- GLOBAL PATENT APPLICATIONS, 2008 AND 2009 116
- TABLE 34 GLOBAL CATHETER PATENT APPLICATIONS, 2008-2009 117
- CATHETER PATENT ACTIVITY BY ASSIGNEE 117
- TABLE 35 CATHETER PATENT APPLICATION ACTIVITY BY ASSIGNEE, JANUARY
2007-JUNE 2009 (NUMBER OF PATENTS) 117
- TABLE 35 (CONTINUED) 118
- GLOBALLY ISSUED PATENTS, BY SEGMENT 118
- TABLE 36 GLOBAL PATENTS ISSUED, BY SEGMENT, 2008-2009 118
- TABLE 37 ISSUED CATHETER PATENT SHARES, BY SEGMENT, JANUARY 2007-JUNE
2009 (%) 119
- FIGURE 11 SHARE FOR ISSUED CATHETER PATENTS, BY SEGMENT, JANUARY 2007-JUNE
2009 (%) 119
- CARDIOVASCULAR CATHETER PATENTS 120
- TABLE 38 ISSUED CARDIOVASCULAR CATHETER PATENTS BY TYPE, MAY 2007-MAY 2009
120
- FIGURE 12 ISSUED CARDIOVASCULAR CATHETER PATENTS, BY TYPE, MAY 2007-MAY
2009 (%) 120
- UROLOGY CATHETER PATENTS 121
- TABLE 39 ISSUED UROLOGY CATHETER PATENTS BY TYPE, JANUARY 2007-JUNE 2009
121
- IV CATHETER PATENTS 121
- TABLE 40 ISSUED IV CATHETER PATENTS BY TYPE, MAY 2007-MAY 2009 122
- SPECIALTY CATHETER PATENTS 122
- NEUROVASCULAR 122
- MAJOR CATHETER PATENT RECIPIENTS FROM 1999 TO MAY 2009 122
- TABLE 41 U.S. CATHETER PATENT NUMBERS BY ASSIGNEE, 1999-MAY 2009 122
- TABLE 41 (CONTINUED) 123
- TABLE 41 (CONTINUED) 124
- FIGURE 13 PERCENT OF CATHETER PATENTS ISSUED TO TOP 10 MANUFACTURERS,
1999-MAY 2009 (%) 124
- FIGURE 13 (CONTINUED) 125
- CATHETER PATENT ACTIVITY BY COUNTRY 125
- TABLE 42 CATHETER PATENT ACTIVITY BY COUNTRY, JANUARY 2008-JUNE 2009
(NUMBER OF PATENTS FILED) 125
- TABLE 42 (CONTINUED) 126
- CONCLUSIONS OF THE PATENT ANALYSIS 126
Chapter-14: COMPANY PROFILES 39
- ABBOTT LABORATORIES 127
- TABLE 43 ABBOTT LABORATORIES' CATHETER PRODUCTS 127
- TABLE 43 (CONTINUED) 128
- ANGIODYNAMICS 128
- TABLE 44 ANGIODYNAMICS CATHETER PRODUCTS 129
- ARROW INTERNATIONAL (SEE TELEFLEX) 129
- ASTRA TECH, INC.-UROLOGY DIVISION 129
- TABLE 45 ASTRA TECH CATHETER PRODUCTS 130
- B BRAUN MELSUNGEN AG 130
- TABLE 46 B BRAUN CATHETER PRODUCTS 131
- BECTON DICKINSON & CO. 131
- TABLE 47 BD CATHETER PRODUCTS 132
- BOSTON SCIENTIFIC 132
- TABLE 48 BOSTON SCIENTIFIC CATHETER PRODUCTS 133
- TABLE 48 (CONTINUED) 134
- CARDINAL HEALTH 134
- TABLE 49 CARDINAL HEALTH CATHETER PRODUCTS 135
- COLOPLAST GROUP 135
- TABLE 50 COLOPLAST CATHETER PRODUCTS 136
- COOK MEDICAL 136
- TABLE 51 COOK MEDICAL CATHETER PRODUCTS 137
- TABLE 51 (CONTINUED) 138
- COVIDIEN (FORMERLY TYCO HEALTHCARE) 138
- TABLE 52 COVIDIEN CATHETER PRODUCTS 138
- TABLE 52 (CONTINUED) 139
- CR BARD 139
- TABLE 53 CR BARD CATHETER PRODUCTS 140
- TABLE 53 (CONTINUED) 141
- EDWARDS LIFESCIENCES 141
- TABLE 54 EDWARDS LIFESCIENCES CATHETER PRODUCTS 142
- EV3 ENDOVASCULAR, INC. 143
- TABLE 55 EV3 CATHETER PRODUCTS 143
- HOLLISTER 144
- TABLE 56 HOLLISTER CATHETER PRODUCTS 144
- HOSPIRA, INC. 144
- TABLE 57 HOSPIRA CATHETER PRODUCTS 145
- IRVINE BIOMEDICAL, INC. (SEE ST. JUDE MEDICAL) 145
- JOHNSON & JOHNSON 145
- TABLE 58 JOHNSON & JOHNSON CATHETER PRODUCTS 146
- TABLE 58 (CONTINUED) 147
- MEDTRONIC, INC. 147
- TABLE 59 MEDTRONIC CATHETER PRODUCTS 148
- MERIT MEDICAL SYSTEMS 148
- TABLE 60 MERIT MEDICAL CATHETER PRODUCTS 149
- ROCHESTER MEDICAL 149
- TABLE 61 ROCHESTER MEDICAL CATHETER PRODUCTS 150
- SMITHS MEDICAL 150
- TABLE 62 SMITHS MEDICAL CATHETER PRODUCTS 151
- TABLE 62 (CONTINUED) 152
- ST. JUDE MEDICAL 152
- TABLE 63 ST. JUDE MEDICAL CATHETER PRODUCTS 153
- TELEFLEX MEDICAL (FORMERLY ARROW INTERNATIONAL) 153
- TABLE 64 ARROW/TELEFLEX MEDICAL CATHETER PRODUCTS 154
- TABLE 64 (CONTINUED) 155
- TERUMO MEDICAL CORP. 155
- TABLE 65 TERUMO CORP. CATHETER PRODUCTS 156
- TABLE 65 (CONTINUED) 157
- TYCO HEALTHCARE (SEE COVIDIEN) 157
- VASCULAR SOLUTIONS 157
- TABLE 66 VASCULAR SOLUTIONS CATHETER PRODUCTS 157
APPENDIX: CATHETER PRODUCTS AND THEIR MANUFACTURERS 158
- TABLE 67 CATHETER PRODUCTS AND MANUFACTURERS 158
- TABLE 67 (CONTINUED) 159
- TABLE 67 (CONTINUED) 160
- TABLE 67 (CONTINUED) 161
- TABLE 67 (CONTINUED) 162
- TABLE 67 (CONTINUED) 163
- TABLE 67 (CONTINUED) 164
- TABLE 67 (CONTINUED) 165
|
 |
